| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 393.971 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 281.87 | 87 |
| GSM780709 | Untreated after 4 days (C3_1) | 270.712 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 339.917 | 88 |
| GSM780720 | Untreated after 4 days (C2_2) | 311.544 | 88 |
| GSM780721 | Untreated after 4 days (C3_2) | 283.863 | 87 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 276.815 | 87 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 353.884 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 325.893 | 88 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 272.886 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 342.233 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 350.661 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 266.15 | 86 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 252.832 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 324.489 | 88 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 279.38 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 288.057 | 87 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 329.964 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 573.594 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 425.607 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 336.998 | 88 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 531.172 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 419.862 | 90 |